<DOC>
	<DOCNO>NCT03101124</DOCNO>
	<brief_summary>Tranexamic acid drug prevents clot blood dissolve hence reduces bleed . It routinely give intravenously many surgical situation risk major bleeding . Concerns regard possible adverse effect intravenous use prevents widespread use , even small surgery . Topical application - use drug directly wound surface- may give high concentration site bleed low concentration rest body , hence low risk adverse effect . Here investigated extent define dose drug absorb systemically - blood stream - apply topically . This compare concentration blood stream administer intravenously . Blood sample obtain defined time interval administration patient receive topical patient receive intravenous administration single dose tranexamic acid . Will le drug enter blood stream apply directly wind ?</brief_summary>
	<brief_title>Serum Concentration Tranexamic Acid After Topical Administration Massive Weight Loss Skin Reducing Surgery</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>plan major skin reduction surgery ( abdominoplasty/panniculectomy ) massive weight loss , plan orthopaedic hip replacement surgery pregnancy breastfeed know allergy tranexamic acid/CyklokapronÂ® ongoing former thromboembolic event know kidney failure , define estimate glomerular filtration rate ( eGFR ) &lt; 60 ml/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Hemostasis , Surgical</keyword>
	<keyword>Tranexamic Acid</keyword>
	<keyword>Antifibrinolytic Agents</keyword>
	<keyword>Administration , Cutaneous</keyword>
	<keyword>Administration , Intravenous</keyword>
	<keyword>Administration , Topical</keyword>
</DOC>